What changed
$TJX — AVOID 📊 | 6 MONTHS THESIS
🎯 FQ1 FY2027 (ends Apr) | reported May 20 | Rev $14.3B | EPS $1.19 vs $1.01 🟢
💡 Consensus expects high-single-digit EPS growth and sustained margin improvement; we believe the market may be overestimating the durability of 17% earnings beats and underestimating the potential for comp deceleration in a normalizing retail environment, which could lead to multiple compression.
📉 Reward/risk: 2.0:1
🏢 Business Quality: 9/10 - Superior execution, strong brand loyalty, net cash balance sheet, and consistent market share gains in off-price retail.
📊 Valuation: Rich – 32x forward P/E vs 5-year average of 25x; EV/EBITDA ~20x; FCF yield sub-1%; premium to historical multiples despite peak comps and margins.
🔮 Catalyst: Q2 FY27 earnings release (estimated August 2026)
💰 Entry: $155, stop $140, target $185
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/TJX0612